The company announced its support for the Digital Medicine Society (DiMe) DATAcc project, which is launching open-access digital measures aimed at accelerating pediatric rare disease research and care. The initiative, highlighted in a January 29 webinar, seeks to reduce friction in research processes and speed the development and delivery of therapies for children with rare diseases, leveraging digital health and AI in healthcare.